Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Duck Hepatitis Virus Vaccine (MEVAC)
- Development stage
- Unknown
- Lead developer
- MEVAC
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous, Intramuscular
01
Overview
Duck Hepatitis Virus Vaccine (MEVAC) is a veterinary vaccine developed by Middle East for Vaccines (MEVAC) for the protection of poultry, specifically ducks, against Duck Hepatitis Virus (DHV). DHV is a highly contagious and often fatal viral disease affecting young ducklings, characterized by rapid onset, liver damage, and high mortality rates. The vaccine is designed to stimulate the avian immune system to produce protective antibodies, thereby reducing morbidity and mortality in duck populations. It is typically administered to breeder ducks to provide maternal immunity to their offspring via the egg or administered directly to young ducklings in endemic areas to induce active immunity.
- Brand names
- MEVAC DHV
- Other names
- Duck Hepatitis Virus VaccineDHV Vaccine
02
Targets
DHAV (Duck hepatitis A virus)
Beyond the preview
Go deeper on Duck Hepatitis Virus Vaccine (MEVAC).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Duck Hepatitis Virus Vaccine (MEVAC).